Sanctuary Advisors’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-12,583
Closed -$1.28M 2559
2025
Q4
$1.28M Buy
12,583
+2,315
+23% +$186K 0.01% 1186
2025
Q3
$562K Sell
10,268
-835
-8% -$41.7K ﹤0.01% 1642
2025
Q2
$590K Buy
11,103
+1,398
+14% +$71K ﹤0.01% 1535
2025
Q1
$420K Sell
9,705
-3,920
-29% -$199K ﹤0.01% 1615
2024
Q4
$763K Buy
13,625
+269
+2% +$16.7K ﹤0.01% 1416
2024
Q3
$707K Sell
13,356
-8,082
-38% -$456K ﹤0.01% 1482
2024
Q2
$1.26M Buy
+21,438
New +$1.18M 0.01% 1064

Other funds holding EXAS

Sanctuary Advisors's EXAS Position: Q1 2026 in Review

Sanctuary Advisors sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 12,583 shares — an estimated $1.28M sold.

Sanctuary Advisors first reported a position in EXAS in Q2 2024 and held it in 7 quarters. The position peaked at $1.28M in Q4 2025. 6 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Sanctuary Advisors reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Sanctuary Advisors sold 12,583 Exact Sciences shares in Q1 2026, an estimated $1.28M.
  • Sanctuary Advisors first reported a position in Exact Sciences in Q2 2024 and held it in 7 quarters.
  • Sanctuary Advisors's Exact Sciences position peaked at $1.28M in Q4 2025.
  • 6 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Sanctuary Advisors's 13F filing for Q1 2026, filed 5 May 2026.